The face-to-face Management Committee and Working Groups meeting of the COST Action project CA21154 - Translational Control in Cancer European Network was held at the Milan Hašek Conference Hall in Prague on April 29-30, 2024. The event brought together key stakeholders, including experts and active participants, to discuss the project's progress and future directions.

The Management Committee Meeting took place on April 29 from 13:00 to 18:00, where set of scientific lectures was presented, and strategic decisions and administrative matters were also addressed. The following day, April 30, was dedicated to the Working Group Meeting, focusing on detailed discussions and collaborative efforts within the working groups.

The meeting was a significant step forward in advancing the goals of the TRANSLACORE project, fostering collaboration, and integrating valuable insights from various experts. The participants' active engagement and contributions were instrumental in shaping the future direction of the project.

[See also MEETING section.](https://translacore.eu/event/face-to-face-management-committee-and-working-groups-meeting-in-prague)


The face-to-face Management Committee and Working Groups meeting of the COST Action project CA21154 - Translational Control in Cancer European Network was held at the Milan Hašek Conference Hall in Prague on April 29-30, 2024. 

The man who organized it and the next one upon whom all blame should rest ...

Let's gather together.

Let's talk.

Let's discuss.

Prague1.png

Face to face MC and WG meeting in Prague

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

Face to face MC and WG meeting in Prague